Why Taking GLP-1s Like Ozempic Before Bariatric Surgery May Not Lead to More Weight Loss
New research shows that using a GLP-1 before bariatric surgery may not increase weight loss. coldsnowstorm · E+/Getty A new study found that using GLP-1 medications, such as Ozempic or Wegovy, before bariatric surgery was not associated with greater weight loss 12 months after the procedure. Researchers also found no significant differences in diabetes control, postoperative complications, length…
A recent study found that taking GLP-1 medications, such as Ozempic or Wegovy, before bariatric surgery does not result in greater weight loss after the procedure. The research, published in JAMA Surgery, followed 383 individuals who underwent bariatric surgery at a single center between 2022 and 2024. Of those participants, 24% were using GLP-1 medications before surgery.
At 12 months post-surgery, there was no significant difference in total body weight loss percentage between those who used GLP-1 medications and those who did not. Factors such as age, BMI, sex, and type of surgery did not affect the weight loss outcomes. Experts suggest that GLP-1 medications may still offer benefits before or after bariatric surgery, including aiding weight loss before the procedure or managing weight regain afterward.
Written by urgent.news from Healthline News's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
